Clinical Trials
31 trialsHepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
HBV-Biomark
Assistance Publique - Hôpitaux de Paris
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Mayo Clinic
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Darul Sehat Hospital
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
Peking Union Medical College Hospital
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
National Taiwan University Hospital
Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients
Post Graduate Institute of Medical Education and Research, Chandigarh
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
M.D. Anderson Cancer Center
Effects of Antiviral Therapy on Patients With HBV-related HCC
First Affiliated Hospital Xi'an Jiaotong University
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
GEHEP-002
Hospital Universitario de Valme
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
Third Affiliated Hospital, Sun Yat-Sen University
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
Beijing Ditan Hospital
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Samsung Medical Center
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
Kyoto University Hospital
ROLFH
University of Arkansas
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Peking University
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
Universitaire Ziekenhuizen KU Leuven
HBV/HCC
Azienda Ospedaliera San Camillo Forlanini
Genetic Analysis of Liver Cancer
Stanford University
PICTURE
Kindai University
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
Kaohsiung Medical University Chung-Ho Memorial Hospital
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
Azienda Ospedaliera San Giovanni Battista
HBV-HCC
Sun Yat-sen University
Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
National Taiwan University Hospital
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
National Taiwan University Hospital